Related Experiment Videos
Capillary deposition of C4d complement fragment and early renal graft loss
H E Feucht1, H Schneeberger, G Hillebrand
1Department of Internal Medicine, Klinikum Innenstadt; Institute of Immunology, Munich, Germany.
Insights
Assessing complement fragment C4d deposition in kidney transplant biopsies helps predict early graft dysfunction. Detecting C4d indicates a higher risk of graft loss, aiding in personalized prognosis for kidney allografts.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Early graft dysfunction in kidney transplantation presents an unpredictable clinical outcome.
- The role of complement activation in early graft dysfunction requires further elucidation.
Purpose of the Study:
- To assess the utility of immunohistological detection of vascular complement fragment C4d deposition in kidney allograft biopsies for predicting early graft dysfunction.
- To establish an individual prognosis for kidney allografts exhibiting early dysfunction.
Main Methods:
- Immunohistological assessment of vascular classical complement activation using C4d deposition in kidney graft biopsies (N = 93).
- Correlation of C4d deposition patterns (generalized, segmental, negative) with early graft dysfunction and one-year graft survival rates.
Main Results:
- Capillary C4d deposition was observed in 51 out of 93 early dysfunctioning grafts.
- Graft survival rates were significantly lower in grafts with generalized (57%) or segmental (63%) C4d deposition compared to C4d-negative grafts (90%) (P = 0.0027).
- Three out of four graft losses in the C4d-negative group showed C4d deposition in follow-up biopsies.
Conclusions:
- Vascular C4d deposition is a clinically relevant factor contributing to early kidney allograft dysfunction.
- Immunohistological assessment of C4d deposition aids in providing an individual prognosis for kidney grafts with early dysfunction.
Abstract:
Clinical outcome of kidney grafts that are affected by the complex syndrome of 'early graft dysfunction' is uncertain and rather unpredictable. In this study, an individual prognosis for dysfunctioning allografts (N = 93) is attempted by the immunohistological assessment of vascular classical complement activation in graft biopsies. Thus, capillary deposition of complement fragment C4d was observed in the majority (N = 51) of early dysfunctioning grafts. In 43 biopsies, abundant deposition of fragment C4d was present in all capillaries, whereas in eight specimens a segmental distribution of capillary C4d was observed. In 42 grafts with early dysfunction no capillary C4d was detectable. Eighteen subsequent graft losses within one year (16 early losses) were recorded in the subgroup with C4d in all capillaries, and three early losses in the group with segmentally distributed C4d. Only four graft losses (3 early losses) were recorded in the C4d-negative group (P = 0.0027; Pearson's chi square test). The resulting one-year graft survival rates (72% for the study group) differed markedly between the subgroups. Grafts with generalized or segmental capillary deposition of C4d had 57% and 63% survival, respectively, contrasted by 90% survival in the C4d-negative group. It is of note, however, that also three of the four grafts that were finally lost within the C4d-negative group, showed distinct capillary deposition of C4d in second biopsies. Vascular deposition of complement fragment C4d therefore represents a clinically relevant factor that contributes to early graft dysfunction. Its assessment is helpful for an individual graft prognosis.